nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefaclor—SLC15A1—Lisinopril—systemic scleroderma	0.382	0.572	CbGbCtD
Cefaclor—SLC15A1—Captopril—systemic scleroderma	0.286	0.428	CbGbCtD
Cefaclor—MPO—artery—systemic scleroderma	0.00351	0.227	CbGeAlD
Cefaclor—MPO—endothelium—systemic scleroderma	0.00297	0.192	CbGeAlD
Cefaclor—MPO—blood vessel—systemic scleroderma	0.00274	0.177	CbGeAlD
Cefaclor—MPO—connective tissue—systemic scleroderma	0.0014	0.0908	CbGeAlD
Cefaclor—MPO—skin of body—systemic scleroderma	0.00127	0.082	CbGeAlD
Cefaclor—SLC15A1—digestive system—systemic scleroderma	0.00113	0.0729	CbGeAlD
Cefaclor—MPO—digestive system—systemic scleroderma	0.00101	0.0656	CbGeAlD
Cefaclor—MPO—lung—systemic scleroderma	0.000846	0.0548	CbGeAlD
Cefaclor—SLC15A2—lung—systemic scleroderma	0.000588	0.038	CbGeAlD
Cefaclor—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000276	0.000872	CcSEcCtD
Cefaclor—Insomnia—Mycophenolic acid—systemic scleroderma	0.000276	0.000871	CcSEcCtD
Cefaclor—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000274	0.000868	CcSEcCtD
Cefaclor—Oedema—Lisinopril—systemic scleroderma	0.000274	0.000868	CcSEcCtD
Cefaclor—Pruritus—Captopril—systemic scleroderma	0.000274	0.000867	CcSEcCtD
Cefaclor—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000274	0.000865	CcSEcCtD
Cefaclor—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000864	CcSEcCtD
Cefaclor—Pain—Leflunomide—systemic scleroderma	0.000273	0.000864	CcSEcCtD
Cefaclor—Constipation—Leflunomide—systemic scleroderma	0.000273	0.000864	CcSEcCtD
Cefaclor—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000272	0.000859	CcSEcCtD
Cefaclor—Somnolence—Mycophenolic acid—systemic scleroderma	0.000271	0.000856	CcSEcCtD
Cefaclor—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000271	0.000856	CcSEcCtD
Cefaclor—Shock—Lisinopril—systemic scleroderma	0.00027	0.000854	CcSEcCtD
Cefaclor—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000269	0.000851	CcSEcCtD
Cefaclor—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000269	0.00085	CcSEcCtD
Cefaclor—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000268	0.000848	CcSEcCtD
Cefaclor—Neutropenia—Prednisone—systemic scleroderma	0.000268	0.000847	CcSEcCtD
Cefaclor—Abdominal pain—Azathioprine—systemic scleroderma	0.000267	0.000845	CcSEcCtD
Cefaclor—Body temperature increased—Azathioprine—systemic scleroderma	0.000267	0.000845	CcSEcCtD
Cefaclor—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000266	0.00084	CcSEcCtD
Cefaclor—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000265	0.000839	CcSEcCtD
Cefaclor—Diarrhoea—Captopril—systemic scleroderma	0.000265	0.000838	CcSEcCtD
Cefaclor—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000265	0.000838	CcSEcCtD
Cefaclor—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000265	0.000837	CcSEcCtD
Cefaclor—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000264	0.000835	CcSEcCtD
Cefaclor—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000264	0.000834	CcSEcCtD
Cefaclor—Feeling abnormal—Leflunomide—systemic scleroderma	0.000263	0.000832	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000263	0.000832	CcSEcCtD
Cefaclor—Nausea—Mometasone—systemic scleroderma	0.000262	0.000829	CcSEcCtD
Cefaclor—Anorexia—Lisinopril—systemic scleroderma	0.000262	0.000827	CcSEcCtD
Cefaclor—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000261	0.000826	CcSEcCtD
Cefaclor—Pain—Mycophenolic acid—systemic scleroderma	0.000261	0.000824	CcSEcCtD
Cefaclor—Constipation—Mycophenolic acid—systemic scleroderma	0.000261	0.000824	CcSEcCtD
Cefaclor—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000823	CcSEcCtD
Cefaclor—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000259	0.000819	CcSEcCtD
Cefaclor—Cough—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000813	CcSEcCtD
Cefaclor—Hypotension—Lisinopril—systemic scleroderma	0.000256	0.000811	CcSEcCtD
Cefaclor—Dizziness—Captopril—systemic scleroderma	0.000256	0.00081	CcSEcCtD
Cefaclor—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000807	CcSEcCtD
Cefaclor—Urticaria—Leflunomide—systemic scleroderma	0.000254	0.000802	CcSEcCtD
Cefaclor—Abdominal pain—Leflunomide—systemic scleroderma	0.000252	0.000798	CcSEcCtD
Cefaclor—Body temperature increased—Leflunomide—systemic scleroderma	0.000252	0.000798	CcSEcCtD
Cefaclor—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000251	0.000794	CcSEcCtD
Cefaclor—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000793	CcSEcCtD
Cefaclor—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000793	CcSEcCtD
Cefaclor—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000793	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00025	0.000791	CcSEcCtD
Cefaclor—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00025	0.00079	CcSEcCtD
Cefaclor—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00025	0.000789	CcSEcCtD
Cefaclor—Hypersensitivity—Azathioprine—systemic scleroderma	0.000249	0.000788	CcSEcCtD
Cefaclor—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000249	0.000788	CcSEcCtD
Cefaclor—Insomnia—Lisinopril—systemic scleroderma	0.000248	0.000785	CcSEcCtD
Cefaclor—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000248	0.000784	CcSEcCtD
Cefaclor—Paraesthesia—Lisinopril—systemic scleroderma	0.000246	0.000779	CcSEcCtD
Cefaclor—Vomiting—Captopril—systemic scleroderma	0.000246	0.000779	CcSEcCtD
Cefaclor—Dyspnoea—Lisinopril—systemic scleroderma	0.000245	0.000774	CcSEcCtD
Cefaclor—Rash—Captopril—systemic scleroderma	0.000244	0.000773	CcSEcCtD
Cefaclor—Dermatitis—Captopril—systemic scleroderma	0.000244	0.000772	CcSEcCtD
Cefaclor—Somnolence—Lisinopril—systemic scleroderma	0.000244	0.000771	CcSEcCtD
Cefaclor—Headache—Captopril—systemic scleroderma	0.000243	0.000768	CcSEcCtD
Cefaclor—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000767	CcSEcCtD
Cefaclor—Dyspepsia—Lisinopril—systemic scleroderma	0.000242	0.000764	CcSEcCtD
Cefaclor—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000241	0.000762	CcSEcCtD
Cefaclor—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000241	0.000762	CcSEcCtD
Cefaclor—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00024	0.00076	CcSEcCtD
Cefaclor—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00024	0.00076	CcSEcCtD
Cefaclor—Asthma—Methotrexate—systemic scleroderma	0.00024	0.000757	CcSEcCtD
Cefaclor—Decreased appetite—Lisinopril—systemic scleroderma	0.000239	0.000754	CcSEcCtD
Cefaclor—Eosinophilia—Methotrexate—systemic scleroderma	0.000237	0.00075	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000237	0.000749	CcSEcCtD
Cefaclor—Shock—Mycophenolate mofetil—systemic scleroderma	0.000237	0.000748	CcSEcCtD
Cefaclor—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000746	CcSEcCtD
Cefaclor—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000235	0.000744	CcSEcCtD
Cefaclor—Hypersensitivity—Leflunomide—systemic scleroderma	0.000235	0.000744	CcSEcCtD
Cefaclor—Pain—Lisinopril—systemic scleroderma	0.000235	0.000742	CcSEcCtD
Cefaclor—Constipation—Lisinopril—systemic scleroderma	0.000235	0.000742	CcSEcCtD
Cefaclor—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000735	CcSEcCtD
Cefaclor—Diarrhoea—Azathioprine—systemic scleroderma	0.000231	0.000732	CcSEcCtD
Cefaclor—Haemoglobin—Prednisone—systemic scleroderma	0.000231	0.000729	CcSEcCtD
Cefaclor—Nausea—Captopril—systemic scleroderma	0.00023	0.000728	CcSEcCtD
Cefaclor—Haemorrhage—Prednisone—systemic scleroderma	0.000229	0.000725	CcSEcCtD
Cefaclor—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000229	0.000725	CcSEcCtD
Cefaclor—Asthenia—Leflunomide—systemic scleroderma	0.000229	0.000725	CcSEcCtD
Cefaclor—Hallucination—Prednisone—systemic scleroderma	0.000228	0.000722	CcSEcCtD
Cefaclor—Pancytopenia—Methotrexate—systemic scleroderma	0.000227	0.000719	CcSEcCtD
Cefaclor—Feeling abnormal—Lisinopril—systemic scleroderma	0.000226	0.000715	CcSEcCtD
Cefaclor—Pruritus—Leflunomide—systemic scleroderma	0.000226	0.000715	CcSEcCtD
Cefaclor—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000225	0.00071	CcSEcCtD
Cefaclor—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000224	0.00071	CcSEcCtD
Cefaclor—Neutropenia—Methotrexate—systemic scleroderma	0.000224	0.000708	CcSEcCtD
Cefaclor—Dysuria—Methotrexate—systemic scleroderma	0.000224	0.000708	CcSEcCtD
Cefaclor—Dizziness—Azathioprine—systemic scleroderma	0.000224	0.000707	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000693	CcSEcCtD
Cefaclor—Asthenia—Mycophenolic acid—systemic scleroderma	0.000219	0.000691	CcSEcCtD
Cefaclor—Diarrhoea—Leflunomide—systemic scleroderma	0.000219	0.000691	CcSEcCtD
Cefaclor—Urticaria—Lisinopril—systemic scleroderma	0.000218	0.000689	CcSEcCtD
Cefaclor—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000688	CcSEcCtD
Cefaclor—Abdominal pain—Lisinopril—systemic scleroderma	0.000217	0.000686	CcSEcCtD
Cefaclor—Body temperature increased—Lisinopril—systemic scleroderma	0.000217	0.000686	CcSEcCtD
Cefaclor—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000683	CcSEcCtD
Cefaclor—Pruritus—Mycophenolic acid—systemic scleroderma	0.000216	0.000682	CcSEcCtD
Cefaclor—Vomiting—Azathioprine—systemic scleroderma	0.000215	0.00068	CcSEcCtD
Cefaclor—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000678	CcSEcCtD
Cefaclor—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000676	CcSEcCtD
Cefaclor—Infestation—Methotrexate—systemic scleroderma	0.000214	0.000675	CcSEcCtD
Cefaclor—Infestation NOS—Methotrexate—systemic scleroderma	0.000214	0.000675	CcSEcCtD
Cefaclor—Rash—Azathioprine—systemic scleroderma	0.000213	0.000674	CcSEcCtD
Cefaclor—Dermatitis—Azathioprine—systemic scleroderma	0.000213	0.000674	CcSEcCtD
Cefaclor—Headache—Azathioprine—systemic scleroderma	0.000212	0.00067	CcSEcCtD
Cefaclor—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000212	0.00067	CcSEcCtD
Cefaclor—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000212	0.000669	CcSEcCtD
Cefaclor—Dizziness—Leflunomide—systemic scleroderma	0.000211	0.000668	CcSEcCtD
Cefaclor—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000209	0.000661	CcSEcCtD
Cefaclor—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000208	0.000659	CcSEcCtD
Cefaclor—Conjunctivitis—Methotrexate—systemic scleroderma	0.000208	0.000656	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000208	0.000656	CcSEcCtD
Cefaclor—Immune system disorder—Prednisone—systemic scleroderma	0.000207	0.000655	CcSEcCtD
Cefaclor—Pain—Mycophenolate mofetil—systemic scleroderma	0.000206	0.00065	CcSEcCtD
Cefaclor—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000206	0.00065	CcSEcCtD
Cefaclor—Sweating—Methotrexate—systemic scleroderma	0.000205	0.000647	CcSEcCtD
Cefaclor—Haematuria—Methotrexate—systemic scleroderma	0.000204	0.000644	CcSEcCtD
Cefaclor—Vomiting—Leflunomide—systemic scleroderma	0.000203	0.000642	CcSEcCtD
Cefaclor—Hypersensitivity—Lisinopril—systemic scleroderma	0.000202	0.000639	CcSEcCtD
Cefaclor—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000202	0.000639	CcSEcCtD
Cefaclor—Dizziness—Mycophenolic acid—systemic scleroderma	0.000201	0.000637	CcSEcCtD
Cefaclor—Epistaxis—Methotrexate—systemic scleroderma	0.000201	0.000637	CcSEcCtD
Cefaclor—Rash—Leflunomide—systemic scleroderma	0.000201	0.000637	CcSEcCtD
Cefaclor—Dermatitis—Leflunomide—systemic scleroderma	0.000201	0.000636	CcSEcCtD
Cefaclor—Nausea—Azathioprine—systemic scleroderma	0.000201	0.000635	CcSEcCtD
Cefaclor—Headache—Leflunomide—systemic scleroderma	0.0002	0.000633	CcSEcCtD
Cefaclor—Agranulocytosis—Methotrexate—systemic scleroderma	0.000199	0.00063	CcSEcCtD
Cefaclor—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000627	CcSEcCtD
Cefaclor—Asthenia—Lisinopril—systemic scleroderma	0.000197	0.000623	CcSEcCtD
Cefaclor—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000622	CcSEcCtD
Cefaclor—Pruritus—Lisinopril—systemic scleroderma	0.000194	0.000614	CcSEcCtD
Cefaclor—Vomiting—Mycophenolic acid—systemic scleroderma	0.000194	0.000613	CcSEcCtD
Cefaclor—Haemoglobin—Methotrexate—systemic scleroderma	0.000193	0.000609	CcSEcCtD
Cefaclor—Rash—Mycophenolic acid—systemic scleroderma	0.000192	0.000607	CcSEcCtD
Cefaclor—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000192	0.000607	CcSEcCtD
Cefaclor—Hepatitis—Methotrexate—systemic scleroderma	0.000192	0.000606	CcSEcCtD
Cefaclor—Haemorrhage—Methotrexate—systemic scleroderma	0.000192	0.000606	CcSEcCtD
Cefaclor—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000604	CcSEcCtD
Cefaclor—Headache—Mycophenolic acid—systemic scleroderma	0.000191	0.000604	CcSEcCtD
Cefaclor—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00019	0.000601	CcSEcCtD
Cefaclor—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00019	0.000601	CcSEcCtD
Cefaclor—Nausea—Leflunomide—systemic scleroderma	0.00019	0.0006	CcSEcCtD
Cefaclor—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000189	0.000599	CcSEcCtD
Cefaclor—Urethral disorder—Methotrexate—systemic scleroderma	0.000188	0.000594	CcSEcCtD
Cefaclor—Diarrhoea—Lisinopril—systemic scleroderma	0.000188	0.000594	CcSEcCtD
Cefaclor—Ill-defined disorder—Prednisone—systemic scleroderma	0.000185	0.000586	CcSEcCtD
Cefaclor—Agitation—Prednisone—systemic scleroderma	0.000184	0.00058	CcSEcCtD
Cefaclor—Angioedema—Prednisone—systemic scleroderma	0.000182	0.000577	CcSEcCtD
Cefaclor—Dizziness—Lisinopril—systemic scleroderma	0.000181	0.000574	CcSEcCtD
Cefaclor—Erythema multiforme—Methotrexate—systemic scleroderma	0.000181	0.000573	CcSEcCtD
Cefaclor—Nausea—Mycophenolic acid—systemic scleroderma	0.000181	0.000572	CcSEcCtD
Cefaclor—Malaise—Prednisone—systemic scleroderma	0.00018	0.000569	CcSEcCtD
Cefaclor—Vertigo—Prednisone—systemic scleroderma	0.000179	0.000567	CcSEcCtD
Cefaclor—Syncope—Prednisone—systemic scleroderma	0.000179	0.000566	CcSEcCtD
Cefaclor—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000177	0.00056	CcSEcCtD
Cefaclor—Loss of consciousness—Prednisone—systemic scleroderma	0.000176	0.000555	CcSEcCtD
Cefaclor—Vomiting—Lisinopril—systemic scleroderma	0.000174	0.000552	CcSEcCtD
Cefaclor—Immune system disorder—Methotrexate—systemic scleroderma	0.000173	0.000548	CcSEcCtD
Cefaclor—Rash—Lisinopril—systemic scleroderma	0.000173	0.000547	CcSEcCtD
Cefaclor—Convulsion—Prednisone—systemic scleroderma	0.000173	0.000547	CcSEcCtD
Cefaclor—Dermatitis—Lisinopril—systemic scleroderma	0.000173	0.000547	CcSEcCtD
Cefaclor—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000546	CcSEcCtD
Cefaclor—Chills—Methotrexate—systemic scleroderma	0.000172	0.000544	CcSEcCtD
Cefaclor—Headache—Lisinopril—systemic scleroderma	0.000172	0.000544	CcSEcCtD
Cefaclor—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000538	CcSEcCtD
Cefaclor—Arthralgia—Prednisone—systemic scleroderma	0.00017	0.000538	CcSEcCtD
Cefaclor—Myalgia—Prednisone—systemic scleroderma	0.00017	0.000538	CcSEcCtD
Cefaclor—Anxiety—Prednisone—systemic scleroderma	0.000169	0.000536	CcSEcCtD
Cefaclor—Discomfort—Prednisone—systemic scleroderma	0.000168	0.000531	CcSEcCtD
Cefaclor—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000165	0.00052	CcSEcCtD
Cefaclor—Nausea—Lisinopril—systemic scleroderma	0.000163	0.000515	CcSEcCtD
Cefaclor—Oedema—Prednisone—systemic scleroderma	0.000163	0.000515	CcSEcCtD
Cefaclor—Anaphylactic shock—Prednisone—systemic scleroderma	0.000163	0.000515	CcSEcCtD
Cefaclor—Back pain—Methotrexate—systemic scleroderma	0.000161	0.00051	CcSEcCtD
Cefaclor—Shock—Prednisone—systemic scleroderma	0.00016	0.000507	CcSEcCtD
Cefaclor—Nervous system disorder—Prednisone—systemic scleroderma	0.00016	0.000505	CcSEcCtD
Cefaclor—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000503	CcSEcCtD
Cefaclor—Hyperhidrosis—Prednisone—systemic scleroderma	0.000158	0.000498	CcSEcCtD
Cefaclor—Anorexia—Prednisone—systemic scleroderma	0.000155	0.000491	CcSEcCtD
Cefaclor—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000155	0.00049	CcSEcCtD
Cefaclor—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000483	CcSEcCtD
Cefaclor—Rash—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000479	CcSEcCtD
Cefaclor—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000479	CcSEcCtD
Cefaclor—Headache—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000476	CcSEcCtD
Cefaclor—Malaise—Methotrexate—systemic scleroderma	0.000151	0.000476	CcSEcCtD
Cefaclor—Vertigo—Methotrexate—systemic scleroderma	0.00015	0.000474	CcSEcCtD
Cefaclor—Leukopenia—Methotrexate—systemic scleroderma	0.000149	0.000472	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000148	0.00047	CcSEcCtD
Cefaclor—Insomnia—Prednisone—systemic scleroderma	0.000147	0.000466	CcSEcCtD
Cefaclor—Paraesthesia—Prednisone—systemic scleroderma	0.000146	0.000463	CcSEcCtD
Cefaclor—Cough—Methotrexate—systemic scleroderma	0.000146	0.000461	CcSEcCtD
Cefaclor—Convulsion—Methotrexate—systemic scleroderma	0.000145	0.000457	CcSEcCtD
Cefaclor—Dyspepsia—Prednisone—systemic scleroderma	0.000143	0.000454	CcSEcCtD
Cefaclor—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000452	CcSEcCtD
Cefaclor—Chest pain—Methotrexate—systemic scleroderma	0.000142	0.000449	CcSEcCtD
Cefaclor—Myalgia—Methotrexate—systemic scleroderma	0.000142	0.000449	CcSEcCtD
Cefaclor—Arthralgia—Methotrexate—systemic scleroderma	0.000142	0.000449	CcSEcCtD
Cefaclor—Decreased appetite—Prednisone—systemic scleroderma	0.000142	0.000448	CcSEcCtD
Cefaclor—Discomfort—Methotrexate—systemic scleroderma	0.00014	0.000444	CcSEcCtD
Cefaclor—Constipation—Prednisone—systemic scleroderma	0.000139	0.000441	CcSEcCtD
Cefaclor—Confusional state—Methotrexate—systemic scleroderma	0.000137	0.000434	CcSEcCtD
Cefaclor—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000136	0.000431	CcSEcCtD
Cefaclor—Feeling abnormal—Prednisone—systemic scleroderma	0.000134	0.000425	CcSEcCtD
Cefaclor—Nervous system disorder—Methotrexate—systemic scleroderma	0.000134	0.000422	CcSEcCtD
Cefaclor—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000133	0.000422	CcSEcCtD
Cefaclor—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000133	0.000421	CcSEcCtD
Cefaclor—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000132	0.000416	CcSEcCtD
Cefaclor—Anorexia—Methotrexate—systemic scleroderma	0.00013	0.000411	CcSEcCtD
Cefaclor—Urticaria—Prednisone—systemic scleroderma	0.000129	0.000409	CcSEcCtD
Cefaclor—Body temperature increased—Prednisone—systemic scleroderma	0.000129	0.000407	CcSEcCtD
Cefaclor—Abdominal pain—Prednisone—systemic scleroderma	0.000129	0.000407	CcSEcCtD
Cefaclor—Hypotension—Methotrexate—systemic scleroderma	0.000127	0.000402	CcSEcCtD
Cefaclor—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000124	0.000392	CcSEcCtD
Cefaclor—Insomnia—Methotrexate—systemic scleroderma	0.000123	0.00039	CcSEcCtD
Cefaclor—Paraesthesia—Methotrexate—systemic scleroderma	0.000122	0.000387	CcSEcCtD
Cefaclor—Dyspnoea—Methotrexate—systemic scleroderma	0.000121	0.000384	CcSEcCtD
Cefaclor—Somnolence—Methotrexate—systemic scleroderma	0.000121	0.000383	CcSEcCtD
Cefaclor—Hypersensitivity—Prednisone—systemic scleroderma	0.00012	0.00038	CcSEcCtD
Cefaclor—Dyspepsia—Methotrexate—systemic scleroderma	0.00012	0.000379	CcSEcCtD
Cefaclor—Decreased appetite—Methotrexate—systemic scleroderma	0.000118	0.000374	CcSEcCtD
Cefaclor—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000118	0.000372	CcSEcCtD
Cefaclor—Asthenia—Prednisone—systemic scleroderma	0.000117	0.00037	CcSEcCtD
Cefaclor—Pain—Methotrexate—systemic scleroderma	0.000116	0.000368	CcSEcCtD
Cefaclor—Pruritus—Prednisone—systemic scleroderma	0.000115	0.000365	CcSEcCtD
Cefaclor—Feeling abnormal—Methotrexate—systemic scleroderma	0.000112	0.000355	CcSEcCtD
Cefaclor—Diarrhoea—Prednisone—systemic scleroderma	0.000112	0.000353	CcSEcCtD
Cefaclor—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000111	0.000352	CcSEcCtD
Cefaclor—Urticaria—Methotrexate—systemic scleroderma	0.000108	0.000342	CcSEcCtD
Cefaclor—Dizziness—Prednisone—systemic scleroderma	0.000108	0.000341	CcSEcCtD
Cefaclor—Abdominal pain—Methotrexate—systemic scleroderma	0.000108	0.00034	CcSEcCtD
Cefaclor—Body temperature increased—Methotrexate—systemic scleroderma	0.000108	0.00034	CcSEcCtD
Cefaclor—Vomiting—Prednisone—systemic scleroderma	0.000104	0.000328	CcSEcCtD
Cefaclor—Rash—Prednisone—systemic scleroderma	0.000103	0.000325	CcSEcCtD
Cefaclor—Dermatitis—Prednisone—systemic scleroderma	0.000103	0.000325	CcSEcCtD
Cefaclor—Headache—Prednisone—systemic scleroderma	0.000102	0.000323	CcSEcCtD
Cefaclor—Hypersensitivity—Methotrexate—systemic scleroderma	0.0001	0.000317	CcSEcCtD
Cefaclor—Asthenia—Methotrexate—systemic scleroderma	9.77e-05	0.000309	CcSEcCtD
Cefaclor—Nausea—Prednisone—systemic scleroderma	9.68e-05	0.000306	CcSEcCtD
Cefaclor—Pruritus—Methotrexate—systemic scleroderma	9.64e-05	0.000305	CcSEcCtD
Cefaclor—Diarrhoea—Methotrexate—systemic scleroderma	9.32e-05	0.000295	CcSEcCtD
Cefaclor—Dizziness—Methotrexate—systemic scleroderma	9.01e-05	0.000285	CcSEcCtD
Cefaclor—Vomiting—Methotrexate—systemic scleroderma	8.66e-05	0.000274	CcSEcCtD
Cefaclor—Rash—Methotrexate—systemic scleroderma	8.59e-05	0.000272	CcSEcCtD
Cefaclor—Dermatitis—Methotrexate—systemic scleroderma	8.58e-05	0.000271	CcSEcCtD
Cefaclor—Headache—Methotrexate—systemic scleroderma	8.53e-05	0.00027	CcSEcCtD
Cefaclor—Nausea—Methotrexate—systemic scleroderma	8.09e-05	0.000256	CcSEcCtD
